These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30337420)

  • 1. BET 1: Haloperidol in cannabinoid hyperemesis syndrome.
    Dida J; Walji N
    Emerg Med J; 2018 Nov; 35(11):711-712. PubMed ID: 30337420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
    Witsil JC; Mycyk MB
    Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
    Smith TN; Walsh A; Forest CP
    JAAPA; 2019 Apr; 32(4):1-5. PubMed ID: 30913155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.
    Richards JR; Gordon BK; Danielson AR; Moulin AK
    Pharmacotherapy; 2017 Jun; 37(6):725-734. PubMed ID: 28370228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
    Kast KA; Gershengoren L
    J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
    Graham J; Barberio M; Wang GS
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing and treating cannabinoid hyperemesis.
    Wilson O; Lutton S; Doherty K
    Emerg Nurse; 2015 Dec; 23(8):22-5. PubMed ID: 26638755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome].
    Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G
    An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
    Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
    Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
    Khattar N; Routsolias JC
    Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
    Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
    Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
    Brown JM; Wilsey MJ; Dhana L; Lonsdale H
    J Psychiatr Pract; 2023 Sep; 29(5):354-358. PubMed ID: 37678364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.
    Sabbineni M; Scott W; Punia K; Manuja K; Singh A; Campbell K; MacKillop J; Balodis I
    Acad Emerg Med; 2024 May; 31(5):493-503. PubMed ID: 37391387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis.
    Pourmand A; Esmailian G; Mazer-Amirshahi M; Lee-Park O; Tran QK
    Am J Emerg Med; 2021 May; 43():35-40. PubMed ID: 33493995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
    Hernandez JM; Paty J; Price IM
    CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.
    McConachie SM; Caputo RA; Wilhelm SM; Kale-Pradhan PB
    Ann Pharmacother; 2019 Nov; 53(11):1145-1152. PubMed ID: 31104487
    [No Abstract]   [Full Text] [Related]  

  • 19. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
    Richards JR
    J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.